# Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies

> **NCT07282548** · — · WITHDRAWN · sponsor: **Ipsen**

## Conditions studied

- Follicular Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07282548
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-06
- **Primary completion:** 2031-06-30
- **Final completion:** 2031-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn prior to enrolment after review of updated safety data
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07282548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07282548, "Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07282548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*